Description
Why It’s Done:
The Del 13q test is used to:
• Diagnose or confirm certain blood cancers, particularly CLL and multiple myeloma.
• Stratify risk and guide treatment decisions—patients with a 13q deletion as the sole abnormality in CLL often have a better prognosis than those with other chromosomal changes.
• Monitor disease progression or response to therapy in individuals already diagnosed with a hematological disorder.
• Evaluate bone marrow function in the context of unexplained cytopenias or abnormal blood counts.
Preparation:
• No special preparation is needed for this test.
• A blood sample or bone marrow sample is required, depending on the clinical situation.
• Inform your doctor of any current medications or ongoing treatments, especially chemotherapy.
